Will the U.S. Be the First to Authorize Moderna's Vaccine?

On Dec. 17, the Food and Drug Administration will consider Moderna's (NASDAQ: MRNA) request for Emergency Use Authorization for its coronavirus vaccine. The biotech company also has approached regulators in other countries. In this Motley Fool Live video recorded on Dec. 11, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com contributor Adria Cimino discuss the potential timeline for authorization of Moderna's investigational vaccine.

Continue reading

Source Fool.com